Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study.

Source:http://linkedlifedata.com/resource/pubmed/id/17267326

Download in:

View as

General Info

PMID
17267326